HCC is the most common primary liver cancer, often arising in patients with chronic liver disease or cirrhosis. Risk factors include hepatitis B or C infection, alcohol use, and non-alcoholic fatty liver disease. Early detection is crucial for curative treatments. Renji Hospital offers a full spectrum of HCC management, including surgical resection, ablation, HAIC, TACE, radiotherapy, and systemic therapies such as targeted agents and immunotherapy.

**Services we provide:** Comprehensive liver cancer management; Minimally invasive liver resection (laparoscopic/robotic); Interventional therapies (TACE/HAIC); Advanced systemic treatment and participation in cutting-edge clinical trials (CAR-T, vaccines, oncolytic viruses).